Concepedia

Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial

Richard M. Bergenstal, Carol Wysham, Leigh MacConell, Jaret Malloy, Brandon Walsh, Ping Yan, Ken Wilhelm, Jim Malone, Lisa E. Porter

The Lancet · 2010 · 605 citations · 29 references

DOI

Concepts

References

29

Markers of Inflammation and Cardiovascular Disease

Thomas A. Pearson, George A. Mensah, R. Wayne Alexander et al. · Circulation · 2003 · 6.3K citations · Full text

, , +24

A sharper Bonferroni procedure for multiple tests of significance

Yosef Hochberg · Biometrika · 1988 · 4.7K citations

, , +14

Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy

David M. Nathan, John B. Buse, Mayer B. Davidson et al. · Diabetes Care · 2008 · 3.8K citations · Full text

, , +14

World Medical Association Declaration of Helsinki

Not Available Not Available · JAMA · 2000 · 2.3K citations

, , +16

Effects of Exenatide (Exendin-4) on Glycemic Control and Weight Over 30 Weeks in Metformin-Treated Patients With Type 2 Diabetes

Ralph A. DeFronzo, Robert E. Ratner, Jenny Han et al. · Diabetes Care · 2005 · 1.5K citations